Exhibit 99.2
Template for notification and public disclosure of transactions by persons discharging manage-rial
responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Martin Nicklasson |
2. | Reason for the notification | |
a) | Position/status | Chairman of the Board of Directors in Zealand Pharma A/S |
b) | Initial notification/Amend-ment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc-tion monitor | |
a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
b) | LEI1 | 549300ITBB1ULBL4CZ12 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) | Description of the financialinstrument, type of instru-ment | Shares | |
Identification code | DK0060257814 | ||
b) | Nature of the transaction | Purchase of shares | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 243,6 | 1.570 | ||
d) | Aggregated information | ||
- Aggregated volume | DKK 382.452 | ||
-Price | |||
e) | Date of the transaction | 20 May 2020 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S |